Analystreport

Apricus Biosciences (NASDAQ: APRI) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating.

APRICUS BIOSCIENCES  (APRI) 
Last apricus biosciences earnings: 11/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: apricusbio.com